Recall Record

Sandy, UT, United States

Becton Dickinson Infusion Therapy Systems, Inc. recalls

7 recalls recorded since 2018, most recently on 21 May 2025. 7 are listed as ongoing. Status and classification are as published by the FDA.

Recalls7
Ongoing (FDA)7
Terminated or completed0
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
21 May 2025
Reason
Due to customer complaints, there is the possibility that catheter needle may be slow to retract or fail to retract.
Distribution
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV and the countries of Belgium, Canada, Chile, Colombia, Guatemala, J
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2007-2025, Z-2006-2025, Z-2005-2025, Z-2002-2025, Z-1999-2025, Z-2003-2025, Z-2001-2025, Z-2004-2025, Z-2000-2025

Ongoing Class II Medical devices

Recall started
21 April 2025
Reason
Due to a manufacturing defect IV catheter may have a hole in the septum, which may result in blood leakage from the septum during insertion, which may cause blood exposure or the need for a second IV to be placed - which may result in therapy delay.
Distribution
Worldwide - US Nationwide distribution in the states of IN, AL, CA, FL, TX, NJ, MO, NC, NY, OH, AZ, MN, MA, WA, OK, KS, MS, LA, MD, GA, TN, NM, PA and the country of CA.
Initiated
Voluntary: Firm initiated
Recall number
Z-1808-2025

Ongoing Class II Medical devices

Recall started
26 June 2024
Reason
Catheters may contain a hole in the catheter tubing, which could result in leakage during the insertion process.
Distribution
US: IL OUS: N/A0
Initiated
Voluntary: Firm initiated
Recall number
Z-2458-2024

Ongoing Class II Medical devices

Recall started
4 October 2023
Reason
Over-the-needle, intravascular catheters may have needles that do not retract properly into the barrel, which could result in contaminated needlestick injury, blood leaking from the insertion site or catheter, and repeat catheter insertion attempts, due to catheter being inadvertently removed from the insertion site.
Distribution
US Nationwide distribution in the states of CA, NC, MI, WA, CO, FL, NJ, NM, IL, KY, TN, OH, TX, IN, LA, IA, MS, MO, NE, MD, NY, PA, GA, VA, ME, SC, RI, MA, PR.
Initiated
Voluntary: Firm initiated
Recall number
Z-0400-2024

Ongoing Class II Medical devices

Recall started
29 August 2023
Reason
There is the potential that the safety shield may not properly engage on IV catheters. The needle can pull through the safety shield and disconnect from the needle safety shield leaving the contaminated needle point exposed.
Distribution
US Nationwide distribution in the states of CA, FL, GA, MA, MN, MO, MS, NJ, OH, TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-0025-2024

Ongoing Class II Medical devices

Recall started
12 October 2022
Reason
During needle withdrawal, the tip shield may prematurely separate from the catheter adapter and preventing the needle tip from being in the safely shielded (leaving the needle tip exposed).
Distribution
U.S.: New York, Florida, Maryland, North Carolina, Virginia, Georgia, Rhode Island, New Jersey, Pennsylvania, Illinois, South Carolina, Maine, and Massachusetts. O.U.S.: N/A
Initiated
Voluntary: Firm initiated
Recall number
Z-0174-2023

Ongoing Class II Medical devices

Recall started
8 September 2021
Reason
There is a breach in the product packaging that renders the product non-sterile.
Distribution
U.S. Nationwide Distribution: AR, AZ, MA, GA, NC, OH, WA, NY, NJ, HI, CA, MD, RI, MT, IN, PA, IL OK, OR, AK, CT, TX, ME, MO, FL, VA, LA, CO, UT O.U.S.: None
Initiated
Voluntary: Firm initiated
Recall number
Z-0306-2022

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.